Skip to content
Federal Trade Commission (FTC) proposals for new rules to permit more aggressive opposition to mergers would interfere with the economic ecosystem that is essential […]
FTC plans for aggressive merger enforcement threaten biotech innovation, BIO says Read More »
One Saturday in 2019, Mike Lavorel went out with some friends and ordered some oysters. By Monday, he was ill and by Tuesday, he
‘Miracle Man’ beat sepsis, but now needs a kidney Read More »
Artificial Intelligence (AI) is saturating every aspect of human life—including life sciences. While the potential of AI and computational biology are vast, one of
How AI and computational biology can help us reach ‘undruggable’ targets Read More »
The wonder of RNA-based technology was long in its coming. But it has paid off throughout the COVID and post-COVID years. Plus, the breadth
RNA presents challenges, enormous opportunities, say biotech leaders Read More »
The law on every company’s and investor’s mind: the Inflation Reduction Act (IRA), which allows the government to set the prices of certain drugs.
How is the Inflation Reduction Act affecting biotech investment? Read More »
When Roy began to lose his vision 20 years ago, he still hoped for a cure for his retinitis pigmentosa (RP). But after being
Nanoscope Therapeutics’ drug brings hope for visually impaired patients Read More »
The Biotechnology Innovation Organization (BIO) Investor Forum 2023 is taking place October 17-18, 2023, in San Francisco, California, bringing together biotech startups and drug
BIO Investor Forum 2023 kicks off – here’s why biotech investment matters Read More »
Women’s health has long been an underserved area when it comes to clinical innovation, R&D, and funding—the Women’s Health Innovation Opportunity Map (WHOM) is
Women’s Health Innovation Opportunity Map launches Read More »
Japanese government and business leaders discussed avenues to strengthen ties between the US and Japanese biotech innovation ecosystems in meetings with a delegation from
BIO confers with officials in Tokyo about Japan’s innovation ecosystem Read More »
A proposed waiver of the World Trade Organization (WTO) intellectual property protections and global plans to prepare for the next pandemic highlighted discussions when
BIO discusses IP and other biotech issues with international officials in Geneva Read More »
